Press Release, Lund March 18, 2021 Today Hamlet Pharma is proud to announce new treatment advances in an experimental model of bladder cancer. A potent…
Read More
Extra bolagsstämman i Hamlet Pharma AB (publ) den 2 mars 2021 beslutade, i enlighet med styrelsens förslag, om en uppdelning (split) av de befintliga utestående…
Idag, den 2 mars 2021, hölls extra bolagsstämma i Hamlet Pharma AB (publ), som mot bakgrund av coronaviruset genomfördes enbart genom förhandsröstning med stöd av…
Pressmeddelande, Lund 29 januari, 2021 Aktieägarna i Hamlet Pharma AB (publ) kallas till extra bolagsstämma tisdagen den 2 mars 2021. Mot bakgrund av coronaviruset genomförs…
Hamlet Pharma AB (publ) föreslår införande av A- och B-aktier med rösträttsdifferentiering och kallar till extra bolagsstämma; Bill Hansson föreslås till ny styrelseledamot i Rolf…
Press Release, Lund January 22, 2021 Hamlet Pharma is proud to announce the inclusion of patients in the dose escalation study of bladder cancer in…
HAMLET Pharma AB is pleased to announce that we have received a notification from the European Patent Office (EPO) regarding a patent application with claims…
Hamlet Pharma takes a further step towards the start of the clinical study in patients with bladder cancer. The company has received ethical approval of…
Hamlet Pharma announces that the production of the Alpha1H peptide has been successful and that the peptide is ready for delivery. The peptide meets the…
On April 11th, the British newspaper The Daily Telegraph published a feature article about HAMLET and the founder of Hamlet Pharma Professor Catharina Svanborg, following…